Intraocular lenses (IOLs) are a type of ophthalmic implants, which are used in surgeries pertaining to eyes. IOLs are synthetic lenses implanted inside the eye that substitute the focusing power of a natural lenses, which are surgically removed. These are used to treat myopia, astigmatism, or cataracts.
The global intraocular lens market generated $3,306 million in 2015, and is projected to reach $4,973 million by 2022, registering a CAGR of 7.0% during the study period. In terms of volume, the market is expected to grow at a CAGR of 7.1%. This is attributed to rise in geriatric population, increase in prevalence of cataract, and rise in initiatives taken by government to eliminate avoidable blindness. Moreover, rise in adoption of premium lens owing to their enhanced visual performance ensures reduced rates of astigmatism, thus supplementing the growth of the market. However, unfavorable reimbursement scenario for premium lens and postoperative complications such as refractive errors are expected to restrain the market growth.
The intraocular lens market is segmented based on type, material, end user, and geography. On the basis of type, the market is bifurcated into monofocal and premium intraocular lens. The premium intraocular lens is sub-segmented into toric, multifocal, accommodating, and others (blue light filtering, phakic, and aspheric intraocular lens). By material, the market is categorized into polymethylmethacrylate (PMMA), silicone, and hydrophobic acrylic. According to end user, it is divided into hospitals, ambulatory surgical centers, ophthalmology clinics, and eye research institutes. Geographically, it is analyzed across North America, Europe, Asia-Pacific, and LAMEA.
Prominent players adopted product development and product launches & approvals as their key developmental strategies to expand their product portfolio. For instance, in July 2016, Abott Medical Optics (now acquired by Johnson & Johnson) received FDA approval for the use of Tecnis Symfony Intraocular lenses for the treatment of cataract.
KEY BENEFITS
This report provides an extensive analysis of the current and emerging market trends and dynamics in the global intraocular lens market.
This study provides the competitive landscape of the global market to predict the competitive environment across geographies.
This report entails the detailed quantitative analysis of the current trends and future estimations to identify the prevailing opportunities.
Comprehensive analysis of factors that drive and restrict the market growth is provided in the report.
Region- and country-wise analysis is provided to understand the market trends and dynamics.
KEY MARKET SEGMENTS
By Type
Monofocal Intraocular Lens
Premium Intraocular Lens
Toric Intraocular Lens
Multifocal Intraocular Lens
Accommodating Intraocular Lens
Others
Blue Light Filtering Intraocular Lens
Phakic Intraocular Lens
Aspheric Intraocular Lens
By Material
Polymethylmethacrylate (PMMA)
Silicone
Hydrophobic Acrylic
By End User
Hospitals
Ambulatory Surgery Centers
Ophthalmology Clinics
Eye Research Institutes
By Region
North America
U.S.
Canada
Mexico
Europe
Germany
France
UK
Italy
Spain
Netherlands
Norway
Russia
Sweden
Switzerland
Rest of Europe
Asia-Pacific
Japan
China
India
Australia
South Korea
New Zealand
Taiwan
Thailand
Rest of Asia-Pacific
LAMEA
Brazil
Saudi Arabia
South Africa
Chile
Columbia
Egypt
Iran
Israel
Turkey
Venezuela
Rest of LAMEA
The key players profiled in this report are as follows:
Alcon, Inc. (division of Novartis AG)
Carl Zeiss Meditec AG
EyeKon Medical, Inc.
HOYA GROUP
HumanOptics AG
Johnson & Johnson
Lenstec, Inc.
Rayner
STAAR Surgical
Valeant
Other players operating in the intraocular lens market include:
PhysIOL s.a.
Calhoun Vision Center
Oculentis GmBH
